Related Experiment Videos
Alginate-based microcapsules for immunoprotected islet transplantation
U Siebers1, A Horcher, R G Bretzel
1Medizinische Klinik III, Justus-Liebig-Universität, Giessen, Germany.
Annals of the New York Academy of Sciences
|June 9, 1998
Summary
Microencapsulation shows promise for islet transplantation in diabetes treatment. However, immune recognition of the encapsulated islet, not just material biocompatibility, is crucial for graft survival.
Area of Science:
- Biomedical Engineering
- Immunology
- Transplantation Science
Background:
- Islet transplantation offers a potential cure for insulin-dependent diabetes mellitus.
- Clinical application is limited by donor scarcity and the need for lifelong immunosuppression to prevent graft rejection.
Purpose of the Study:
- To evaluate microencapsulation as a method for creating an immunoprotected site for islet transplantation.
- To investigate the biocompatibility of encapsulation materials and the immune interactions between encapsulated islets and the host.
Main Methods:
- In vivo transplantation experiments using islets from different donor species.
- In vitro mixed lymphocyte islet culture (MLIC) assays.
- Morphological analysis of tissue reactions to encapsulated islets.
Main Results:
- Graft function longevity depends on islet donor species, indicating recognition despite encapsulation.
- In vitro MLIC confirmed immune recognition of encapsulated islets.
- Increased fibrous tissue formation correlated with greater donor-recipient species disparity.
Conclusions:
- Successful islet transplantation requires considering the entire device (capsule + tissue), not just material biocompatibility.
- Effective immunoprotection involves shielding the graft from immune effectors and preventing host immune system recognition of the graft.